| Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome NJ Samadder, D Riegert-Johnson, L Boardman, D Rhodes, M Wick, ... JAMA oncology 7 (2), 230-237, 2021 | 219 | 2021 |
| Systemic Therapy and Sequencing Options in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-analysis MB Sonbol, IB Riaz, SAA Naqvi, DR Almquist, S Mina, J Almasri, S Shah, ... JAMA oncology, e204930-e204930, 2020 | 170 | 2020 |
| Germline cancer susceptibility gene testing in unselected patients with colorectal adenocarcinoma: a multicenter prospective study PLS Uson Jr, D Riegert-Johnson, L Boardman, J Kisiel, L Mountjoy, ... Clinical Gastroenterology and Hepatology 20 (3), e508-e528, 2022 | 63 | 2022 |
| The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer JE Berchuck, F Facchinetti, DF DiToro, I Baiev, U Majeed, S Reyes, ... Annals of Oncology 33 (12), 1269-1283, 2022 | 59 | 2022 |
| Continuous palliative sedation for patients with advanced cancer at a tertiary care cancer center BL Prado, DBD Gomes, PLS Usón Júnior, P Taranto, MS França, D Eiger, ... BMC Palliative Care 17, 1-7, 2018 | 52 | 2018 |
| Clinical impact of pathogenic germline variants in pancreatic cancer: results from a multicenter, prospective, universal genetic testing study PLS Uson Jr, NJ Samadder, D Riegert-Johnson, L Boardman, MJ Borad, ... Clinical and translational gastroenterology 12 (10), e00414, 2021 | 29 | 2021 |
| Immune checkpoint inhibitors as therapy to down-stage hepatocellular carcinoma prior to liver transplantation NN Katariya, BC Lizaola-Mayo, DM Chascsa, E Giorgakis, BA Aqel, ... Cancers 14 (9), 2056, 2022 | 27 | 2022 |
| A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinoma DH Ahn, PLS Uson Junior, P Masci, H Kosiorek, TR Halfdanarson, ... Investigational new drugs 40 (1), 134-141, 2022 | 27 | 2022 |
| Circulating tumor DNA (ctDNA) based testing and actionable findings in patients with advanced and metastatic pancreatic adenocarcinoma G Botrus, H Kosirorek, MB Sonbol, Y Kusne, PLSU Junior, MJ Borad, ... The oncologist, 2021 | 25 | 2021 |
| Predictive Value of Serum Carbohydrate Antigen 19-9 (CA19-9) for Early Mortality in Advanced Pancreatic Cancer MFC Usón Junior PLS, Callegaro-Filho D, Bugano DDG, Moura F Journal of Gastrointestinal Cancer 49 (4), 481-486, 2017 | 25* | 2017 |
| Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapy MS França, PLS Usón, YPPV Antunes, BL Prado, CC Donnarumma, ... Einstein (Sao Paulo) 13 (2), 221-225, 2015 | 25* | 2015 |
| Meta-analysis of modified FOLFIRINOX regimens for patients with metastatic pancreatic cancer PLSU Junior, ET Rother, FC Maluf, DDG Bugano Clinical Colorectal Cancer 17 (3), 187-197, 2018 | 23 | 2018 |
| The impact of metastatic sites in advanced pancreatic adenocarcinoma, systematic review and meta-analysis of prospective randomized studies PLS Usón, FDAS Tolentino, VM Santos, ET Rother, FC Maluf PloS One 15 (3), e0230060, 2020 | 22 | 2020 |
| Higher overall survival in metastatic pancreatic cancer: the impact of where and how treatment is delivered PLS Usón Junior, MS França, HV Rodrigues, ALV Macedo, A Goldenberg, ... Einstein (Sao Paulo) 13, 347-351, 2015 | 21* | 2015 |
| Precision approaches for cholangiocarcinoma: progress in clinical trials and beyond PLS Uson Junior, MJ Borad Expert Opinion on Investigational Drugs 31 (1), 125-131, 2022 | 17 | 2022 |
| Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancer Cancer Chemotherapy and Pharmacology 8, 10, 2020 | 17* | 2020 |
| Does time-to-chemotherapy impact the outcomes of resected ovarian cancer? Meta-analysis of randomized and observational data PLS Usón, DDG Bugano, MS França, YPPV Antunes, P Taranto, ... International Journal of Gynecologic Cancer 27 (2), 2017 | 17 | 2017 |
| Does neoadjuvant treatment in resectable pancreatic cancer improve overall survival? A systematic review and meta-analysis of randomized controlled trials PLSU Junior, DD e Silva, NM de Castro, E da Silva Victor, ET Rother, ... ESMO open 8 (1), 100771, 2023 | 16 | 2023 |
| Incidental findings in reduction mammoplasty specimens in patients with no prior history of breast cancer. An analysis of 783 specimens PLS Usón Junior, D Callegaro Filho, DDG Bugano, FC Geyer, ... Pathology & Oncology Research 24, 95-99, 2018 | 16 | 2018 |
| Does neoadjuvant treatment in resectable pancreatic cancer improve overall survival PLS Uson Junior, ESD Dias, NM de Castro, E da Silva Victor, ET Rother, ... A systematic review and meta-analysis of randomized controlled trials. ESMO …, 2023 | 14 | 2023 |
Mitesh J. BoradMayo ClinicVerified email at mayo.edu